Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88


A flexible multi-domain test with adaptive weights and its application to clinical trials.

Zhao Y, Yu Q, Lake SL.

Pharm Stat. 2019 Dec 30. doi: 10.1002/pst.1993. [Epub ahead of print]


Vaccination in adults with autoimmune rheumatic diseases.

Kwok TSH, Libman M, Lake SL.

CMAJ. 2019 Sep 9;191(36):E1005. doi: 10.1503/cmaj.190345. No abstract available.


Headache and vision changes in an elderly man with rheumatoid arthritis.

Kwok TSH, Daneman N, Lake SL.

Int J Rheum Dis. 2019 Jul;22(7):1331-1334. doi: 10.1111/1756-185X.13589. Epub 2019 May 22.


Haematobia irritans parasitism of F1 yak × beef cattle (Bos grunniens × Bos taurus) hybrids.

Calkins CM, Scasta JD, Smith T, Stayton MM, Lake SL.

Med Vet Entomol. 2019 Dec;33(4):546-551. doi: 10.1111/mve.12382. Epub 2019 May 20.


Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.

Kenawy N, Kalirai H, Sacco JJ, Lake SL, Heegaard S, Larsen AC, Finger PT, Milman T, Chin K, Mosci C, Lanza F, Moulin A, Schmitt CA, Caujolle JP, Maschi C, Marinkovic M, Taktak AF, Heimann H, Damato BE, Coupland SE.

Pigment Cell Melanoma Res. 2019 Jul;32(4):564-575. doi: 10.1111/pcmr.12767. Epub 2019 Feb 19.


Influence of post-insemination nutrition on embryonic development in beef heifers.

Kruse SG, Bridges GA, Funnell BJ, Bird SL, Lake SL, Arias RP, Amundson OL, Larimore EL, Keisler DH, Perry GA.

Theriogenology. 2017 Mar 1;90:185-190. doi: 10.1016/j.theriogenology.2016.11.021. Epub 2016 Nov 24.


Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis.

Arroyo González R, Kita M, Crayton H, Havrdova E, Margolin DH, Lake SL, Giovannoni G; CARE-MS I and II Investigators.

Mult Scler. 2017 Sep;23(10):1367-1376. doi: 10.1177/1352458516677589. Epub 2016 Nov 25.


Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators.

Neurology. 2016 Nov 8;87(19):1985-1992. Epub 2016 Oct 12.


Early Adolescent Trajectories of Impulsiveness and Sensation Seeking in Children of Fathers with Histories of Alcohol and Other Substance Use Disorders.

Acheson A, Lake SL, Bray BC, Liang Y, Mathias CW, Ryan SR, Charles NE, Dougherty DM.

Alcohol Clin Exp Res. 2016 Dec;40(12):2622-2630. doi: 10.1111/acer.13235. Epub 2016 Oct 5.


Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.

Arnold DL, Fisher E, Brinar VV, Cohen JA, Coles AJ, Giovannoni G, Hartung HP, Havrdova E, Selmaj KW, Stojanovic M, Weiner HL, Lake SL, Margolin DH, Thomas DR, Panzara MA, Compston DA; CARE-MS I and CARE-MS II Investigators.

Neurology. 2016 Oct 4;87(14):1464-1472. Epub 2016 Sep 2.


Pubertal Maturation Compression and Behavioral Impulsivity among Boys at Increased Risk for Substance Use.

Mathias CW, Charles NE, Liang Y, Acheson A, Lake SL, Ryan SR, Olvera RL, Dougherty DM.

Addict Disord Their Treat. 2016 Jun;15(2):61-73.


Family Functioning as a Mediator of Relations between Family History of Substance Use Disorder and Impulsivity.

Ryan SR, Friedman CK, Liang Y, Lake SL, Mathias CW, Charles NE, Acheson A, Dougherty DM.

Addict Disord Their Treat. 2016 Mar;15(1):17-24. Epub 2015 Apr 30.


Aggression as a Predictor of Early Substance Use Initiation among Youth with Family Histories of Substance Use Disorders.

Mathias CW, Duffing TM, Ashley A, Charles NE, Lake SL, Ryan SR, Liang Y, Dougherty DM.

Addict Disord Their Treat. 2015 Dec;14(4):230-240. No abstract available.


Clinical and Social/Environmental Characteristics in a Community Sample of Children With and Without Family Histories of Substance Use Disorder in the San Antonio Area: A Descriptive Study.

Ryan SR, Acheson A, Charles NE, Lake SL, Hernandez DL, Mathias CW, Dougherty DM.

J Child Adolesc Subst Abuse. 2016;25(4):327-339. doi: 10.1080/1067828X.2014.999202. Epub 2016 May 19.


Insights into genetic alterations of liver metastases from uveal melanoma.

McCarthy C, Kalirai H, Lake SL, Dodson A, Damato BE, Coupland SE.

Pigment Cell Melanoma Res. 2016 Jan;29(1):60-7. doi: 10.1111/pcmr.12433.


The Potential Clinical Utility of Transdermal Alcohol Monitoring Data to Estimate the Number of Alcoholic Drinks Consumed.

Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Cates SE, Roache JD.

Addict Disord Their Treat. 2015 Sep;14(3):124-130.


Behavioral Impulsivity and Risk-Taking Trajectories Across Early Adolescence in Youths With and Without Family Histories of Alcohol and Other Drug Use Disorders.

Dougherty DM, Lake SL, Mathias CW, Ryan SR, Bray BC, Charles NE, Acheson A.

Alcohol Clin Exp Res. 2015 Aug;39(8):1501-9. doi: 10.1111/acer.12787. Epub 2015 Jul 14.


Using contingency management procedures to reduce at-risk drinking in heavy drinkers.

Dougherty DM, Lake SL, Hill-Kapturczak N, Liang Y, Karns TE, Mullen J, Roache JD.

Alcohol Clin Exp Res. 2015 Apr;39(4):743-51. doi: 10.1111/acer.12687.


Increased Pre- and Early-Adolescent Stress in Youth with a Family History of Substance Use Disorder and Early Substance Use Initiation.

Charles NE, Mathias CW, Acheson A, Bray BC, Ryan SR, Lake SL, Liang Y, Dougherty DM.

J Youth Adolesc. 2015 Oct;44(10):1954-67. doi: 10.1007/s10964-015-0271-7. Epub 2015 Mar 19.


Assessing the Validity of Participant-Derived Compared to Staff-Derived Values to Compute a Binge Score.

Lake SL, Hill-Kapturczak N, Liang Y, Roache JD, Mullen J, Karns TE, Dougherty DM.

Alcohol Alcohol. 2015 Jul;50(4):413-9. doi: 10.1093/alcalc/agv018. Epub 2015 Mar 13.


Effects of tryptophan depletion and a simulated alcohol binge on impulsivity.

Dougherty DM, Mullen J, Hill-Kapturczak N, Liang Y, Karns TE, Lake SL, Mathias CW, Roache JD.

Exp Clin Psychopharmacol. 2015 Apr;23(2):109-21. doi: 10.1037/a0038943. Epub 2015 Mar 2.


Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.

Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N.

Drug Alcohol Depend. 2015 Mar 1;148:77-84. doi: 10.1016/j.drugalcdep.2014.12.021. Epub 2014 Dec 31. Erratum in: Drug Alcohol Depend. ;149:304.


Do variable rates of alcohol drinking alter the ability to use transdermal alcohol monitors to estimate peak breath alcohol and total number of drinks?

Hill-Kapturczak N, Lake SL, Roache JD, Cates SE, Liang Y, Dougherty DM.

Alcohol Clin Exp Res. 2014 Oct;38(10):2517-22. doi: 10.1111/acer.12528. Epub 2014 Oct 21.


Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.

Küsters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, Lake SL, Rijntjes J, Pfundt R, Küsters B, Wesseling P, Blokx WA, Groenen PJ.

Pathol Oncol Res. 2015 Apr;21(2):439-47. doi: 10.1007/s12253-014-9841-3. Epub 2014 Oct 15.


Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.

Dougherty DM, Hill-Kapturczak N, Liang Y, Karns TE, Cates SE, Lake SL, Mullen J, Roache JD.

Drug Alcohol Depend. 2014 Sep 1;142:301-6. doi: 10.1016/j.drugalcdep.2014.06.039. Epub 2014 Jul 11.


The requirement of GnRH at the beginning of the five-day CO-Synch + controlled internal drug release protocol in beef heifers.

Cruppe LH, Day ML, Abreu FM, Kruse S, Lake SL, Biehl MV, Cipriano RS, Mussard ML, Bridges GA.

J Anim Sci. 2014 Sep;92(9):4198-203. doi: 10.2527/jas.2014-7772. Epub 2014 Jul 23.


Comparison of three CIDR-based fixed-time AI protocols in beef heifers.

Bridges GA, Lake SL, Kruse SG, Bird SL, Funnell BJ, Arias R, Walker JA, Grant JK, Perry GA.

J Anim Sci. 2014 Jul;92(7):3127-33. doi: 10.2527/jas.2013-7404. Epub 2014 May 6.


Early metabolic imprinting events increase marbling scores in fed cattle.

Scheffler JM, McCann MA, Greiner SP, Jiang H, Hanigan MD, Bridges GA, Lake SL, Gerrard DE.

J Anim Sci. 2014 Jan;92(1):320-4. doi: 10.2527/jas.2012-6209. Epub 2013 Nov 15.


Authors’ reply.

Lake SL, Kalirai H, Dodson AR, Coupland SE, Lloyd BH, Damato BE, Taktak AF.

Am J Pathol. 2013 Aug;183(2):638-40. No abstract available.


Transcriptome analysis of a parasitic clade V nematode: comparative analysis of potential molecular anthelmintic targets in Cylicostephanus goldi.

Cwiklinski K, Merga JY, Lake SL, Hartley C, Matthews JB, Paterson S, Hodgkinson JE.

Int J Parasitol. 2013 Oct;43(11):917-27. doi: 10.1016/j.ijpara.2013.06.010. Epub 2013 Aug 1.


Effects of feeding corn modified wet distillers grain plus solubles co-ensiled with chopped whole plant corn on heifer growth performance and diet digestibility in beef cattle.

Arias RP, Unruh-Snyder LJ, Scholljegerdes EJ, Baird AN, Johnson KD, Buckmaster D, Lemenager RP, Lake SL.

J Anim Sci. 2013 Sep;91(9):4366-73. doi: 10.2527/jas.2012-5777. Epub 2013 Jul 3.


Static and dynamic approaches yield similar estimates of the thermal sensitivity of insect metabolism.

Lake SL, MacMillan HA, Williams CM, Sinclair BJ.

J Insect Physiol. 2013 Aug;59(8):761-6. doi: 10.1016/j.jinsphys.2013.04.010. Epub 2013 May 9.


Pharmacotherapy of impulsive aggression: a quality comparison of controlled studies.

Felthous AR, Lake SL, Rundle BK, Stanford MS.

Int J Law Psychiatry. 2013 May-Aug;36(3-4):258-63. doi: 10.1016/j.ijlp.2013.04.017. Epub 2013 Apr 30. Review.


Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.

Lake SL, Damato BE, Kalirai H, Dodson AR, Taktak AF, Lloyd BH, Coupland SE.

Am J Pathol. 2013 Mar;182(3):678-87. doi: 10.1016/j.ajpath.2012.11.036. Epub 2013 Jan 26.


Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Kenawy N, Lake SL, Coupland SE, Damato BE.

Eye (Lond). 2013 Feb;27(2):142-52. doi: 10.1038/eye.2012.254. Epub 2012 Dec 7. Review.


Molecular pathology of uveal melanoma.

Coupland SE, Lake SL, Zeschnigk M, Damato BE.

Eye (Lond). 2013 Feb;27(2):230-42. doi: 10.1038/eye.2012.255. Epub 2012 Dec 7. Review.


Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA; CARE-MS I investigators.

Lancet. 2012 Nov 24;380(9856):1819-28. doi: 10.1016/S0140-6736(12)61769-3. Epub 2012 Nov 1.


Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.

Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.


Determination of the appropriate delivery of prostaglandin F2α in the five-day CO-Synch + controlled intravaginal drug release protocol in suckled beef cows.

Bridges GA, Ahola JK, Brauner C, Cruppe LH, Currin JC, Day ML, Gunn PJ, Jaeger JR, Lake SL, Lamb GC, Marquezini GH, Peel RK, Radunz AE, Stevenson JS, Whittier WD.

J Anim Sci. 2012 Dec;90(13):4814-22. doi: 10.2527/jas.2011-4880. Epub 2012 Aug 7.


Effects of feeding corn modified wet distillers grain plus solubles co-ensiled with direct-cut forage on feedlot performance, carcass characteristics, and diet digestibility of finishing steers.

Arias RP, Unruh-Snyder LJ, Scholljegerdes EJ, Baird AN, Johnson KD, Buckmaster D, Lemenager RP, Lake SL.

J Anim Sci. 2012 Oct;90(10):3574-83. doi: 10.2527/jas.2011-4502. Epub 2012 Jun 4.


Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.

Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Skoromets A, Stolyarov I, Bass A, Sullivan H, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA.

Neurology. 2012 Apr 3;78(14):1069-78. doi: 10.1212/WNL.0b013e31824e8ee7. Epub 2012 Mar 21.


Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.

Lake SL, Kalirai H, Dopierala J, Damato BE, Coupland SE.

Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2647-52. doi: 10.1167/iovs.12-9584.


A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.

Fox EJ, Sullivan HC, Gazda SK, Mayer L, O'Donnell L, Melia K, Lake SL.

Eur J Neurol. 2012 Feb;19(2):307-11. doi: 10.1111/j.1468-1331.2011.03507.x. Epub 2011 Sep 7.


GDF-15: a novel serum marker for metastases in uveal melanoma patients.

Suesskind D, Schatz A, Schnichels S, Coupland SE, Lake SL, Wissinger B, Bartz-Schmidt KU, Henke-Fahle S.

Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):887-95. doi: 10.1007/s00417-011-1786-6. Epub 2011 Sep 1.


Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.

Noon AP, Polański R, El-Fert AY, Kalirai H, Shawki H, Campbell F, Dodson A, Eccles RM, Lloyd BH, Sibson DR, Coupland SE, Lake SL, Parsons K, Vlatković N, Boyd MT.

BJU Int. 2012 Apr;109(8):1250-7. doi: 10.1111/j.1464-410X.2011.10433.x. Epub 2011 Jul 14.


Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes.

Lake SL, Jmor F, Dopierala J, Taktak AF, Coupland SE, Damato BE.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5598-604. doi: 10.1167/iovs.10-6934.


Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities.

Lake SL, Damato BE, Dopierala J, Baudo MM, Taktak AF, Coupland SE.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5559-64. doi: 10.1167/iovs.10-6845.


Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.

Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, Bass AD, Wynn DR, Margolin DH, Lake SL, Moran S, Palmer J, Smith MS, Compston DA.

Lancet Neurol. 2011 Apr;10(4):338-48. doi: 10.1016/S1474-4422(11)70020-5.


Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.

Jones JL, Anderson JM, Phuah CL, Fox EJ, Selmaj K, Margolin D, Lake SL, Palmer J, Thompson SJ, Wilkins A, Webber DJ, Compston DA, Coles AJ.

Brain. 2010 Aug;133(Pt 8):2232-47. doi: 10.1093/brain/awq176. Epub 2010 Jul 21.


Supplemental Content

Support Center